10-QPeriod: Q2 FY2000

CARDINAL HEALTH INC Quarterly Report for Q2 Ended Dec 31, 1999

Filed February 11, 2000For Securities:CAH

Summary

Cardinal Health Inc. (CAH) filed its 10-Q report for the period ending December 30, 1999. The filing provides a snapshot of the company's financial performance and operational highlights during the third quarter of its fiscal year. Investors should note the company's continued growth trajectory and its strategic positioning within the healthcare distribution and services sector. While the provided text is a directory listing and does not contain the specific financial statements or management discussion, the context of this filing in early 2000 suggests a company navigating a period of significant expansion and industry consolidation. Investors would typically look for details on revenue growth, profitability margins, debt levels, and any significant acquisitions or divestitures to assess the company's health and future prospects.

Key Highlights

  • 1Filing Date: February 10, 2000, for the period ending December 30, 1999.
  • 2Company: Cardinal Health Inc. (CAH).
  • 3Report Type: Quarterly Report (10-Q).
  • 4Indicates continued operational activity and financial reporting for CAH.
  • 5Filed during a period of potential growth and consolidation in the healthcare industry.
  • 6Provides essential information for investors monitoring CAH's financial health and strategic direction.
  • 7This directory listing serves as an entry point to more detailed financial information within the SEC EDGAR system.

Frequently Asked Questions

This filing is a Form 10-Q, which is a quarterly report filed by publicly traded companies with the U.S. Securities and Exchange Commission (SEC). Its purpose is to provide investors with a comprehensive update on the company's financial performance and operational status during the specified quarter.

Investors typically scrutinize revenue, net income (profitability), earnings per share (EPS), cash flows from operations, and balance sheet items such as debt levels and liquidity. For Cardinal Health specifically, given its industry, looking at trends in sales of medical products and pharmaceuticals, as well as any acquisition-related impacts, would be crucial.

The provided text is a directory listing for the filing. To access the detailed financial statements, notes to the financial statements, and the Management's Discussion and Analysis (MD&A) section, you would need to click on the link to the main filing document (typically a .txt or HTML file) within the EDGAR system. The directory lists files like '-00-000968.txt' which would likely contain the full report.

The late 1990s and early 2000s were a period of significant consolidation and growth in the healthcare industry. Companies like Cardinal Health, involved in pharmaceutical distribution and medical product supply, were often expanding their reach through acquisitions and organic growth to gain scale and efficiency. This environment likely presented both opportunities and challenges for managing growth and integrating operations.